THE EFFECT OF PERFORAN ON THE MOOD SYMPTOMS OF PREMENSTRUAL SYNDROME

Kheirkhah, M and Hassani, M and Aghahosseini, F and Jahdi, F and Abassinia, K (2013) THE EFFECT OF PERFORAN ON THE MOOD SYMPTOMS OF PREMENSTRUAL SYNDROME. The Journal of Urmia Nursing and Midwifery Faculty, 11 (3). pp. 245-251.

Preview

Text 9 Kheirkhah (Abbasinia).pdf Download (151kB) | Preview

Abstract

Premenstrual syndrome is a group of cyclic symptoms that occur during the luteal phase of the menstrual cycle. Materials & Methods: The study was a randomized, double blinded, placebo- controlled trial, with two treatment group. The students of this study are divided randomly into two groups of Perforan group (480 mg) and placebo control group. All the students in this study took drugs during three subsequent cycles so that each person took two capsules daily in the first cycle for one month. In the second and third cycles, they took the drugs from eight days before menstruation to two days after it, and they recorded the severity of the symptoms of her menstruation in the questionnaire of the symptoms. Result: The results showed a reduction of symptoms in treatment drug group comparing to the placebo. So that the mean severity was reported 23.64 in the Perforan group, and 46.37with (p=0.001) in the placebo group. Conclusion: Mean severity of mood symptoms premenstrual syndrome has showed that Perforan can reduce the mood symptoms of premenstrual syndrome more than the placebo group.

Actions (login required)

View Item